C-C motif chemokine ligand 5 messenger RNA (CCL5 mRNA) (CCL5 mRNA)

C-C motif chemokine ligand 5 (CCL5) mRNA is the genetic template for the synthesis of the RANTES protein, a potent chemoattractant for various immune cells including T cells, natural killer cells, and macrophages [1: UniProt P13501]. This mRNA is expressed by a wide range of cell types, including activated T cells, macrophages, and fibroblasts, in response to inflammatory stimuli [2: NCBI Gene ID 6352]. In clinical oncology, elevated levels of CCL5 mRNA are frequently observed in the tumor microenvironment, where they correlate with advanced disease stages and poor prognosis by promoting tumor cell migration and immune evasion [3: PubMed 25617444]. Beyond cancer, CCL5 mRNA plays a significant role in the pathogenesis of chronic inflammatory diseases like asthma and rheumatoid arthritis, as well as in viral infections such as HIV-1, where it influences viral entry and replication [4: PubMed 11169395]. Therapeutic targeting of CCL5 mRNA using RNA interference (RNAi) or antisense oligonucleotides (ASOs) represents a precision medicine approach to silence the production of the pro-inflammatory chemokine at the pre-translational level [5: PubMed 28813325]. Such strategies are designed to overcome the limitations of monoclonal antibodies or small molecule inhibitors by providing more durable and specific suppression of the CCL5 signaling axis [6: PubMed 31434056].

Other names

RANTES mRNASmall inducible cytokine A5 mRNASCYA5 mRNARegulated on Activation, Normal T Cell Expressed and Secreted mRNA

RNA interference (RNAi) or antisense-mediated degradation of the mRNA transcript to prevent translation of the CCL5 protein.